<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70632">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02059941</url>
  </required_header>
  <id_info>
    <org_study_id>44679-J</org_study_id>
    <nct_id>NCT02059941</nct_id>
  </id_info>
  <brief_title>Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines</brief_title>
  <official_title>Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP)- Guidelines Development and Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Management of intracranial hypertension (ICH) in patients with severe traumatic brain injury
      (sTBI) is crucial to their survival and optimal recovery.  The evidence-based Guidelines for
      the Management of Severe Traumatic Brain Injury, 3rd Edition recommends use of intracranial
      pressure (ICP) monitors to assess ICH and guide intervention.  Unfortunately, only a small
      percentage of the world has the resources and capability to routinely monitor ICP.

      The objective of this proposal is to create and test guidelines for the treatment of severe
      TBI in the absence of ICP monitoring.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cognitive Function Scales</measure>
    <time_frame>up to six months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">780</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In this study, there will be about 780 study subjects from 14 sites in Latin America.
        Subjects will be about 390 from clinical sites previously exposed to protocols for
        management of TBI, and about 390 from sites without prior exposure to protocols.  Half of
        the study subjects (about 390 total) will be treated in accordance with a consensus-based
        protocol.  Subjects will consist of patients with TBIs sufficiently severe to fulfill the
        inclusion criteria. To qualify, patients must be 13 or older and have a non-penetrating
        traumatic brain injury. The major criterion is severe TBI to be treated without the use of
        intracranial pressure monitoring
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-penetrating TBI

          -  Post-resuscitation Glasgow Coma Scale score (GCS) ≤ 8, and GCS Motor score ≤ 5, or
             Deterioration to those values within 48 hours of injury

          -  Age 13 years or older

          -  Consent to participate signed by Legally Authorized Representative (LAR)

        Exclusion Criteria:

          -  GCS of 3 with bilateral fixed and dilated pupils and/or decision to not actively
             treat prior to enrolment into study

          -  Prisoner

          -  No consent

          -  Non-survivable injury

          -  Other (e.g., Pre-injury life expectancy under 1 year)

          -  Pre-existing neurological disability that would not allow follow-up
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randall M Chesnut, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Lujan, MD</last_name>
    <phone>549-341-560-9239</phone>
    <email>silviablujan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gustavo Petroni, MD</last_name>
    <phone>549-341-485-5074</phone>
    <email>gustavopetroni@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Viedma</name>
      <address>
        <city>Cochabamba</city>
        <country>Bolivia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis A Lavadenz, MD</last_name>
      <phone>591-72709559</phone>
    </contact>
    <contact_backup>
      <last_name>Siliva Lujan, MD</last_name>
      <phone>549-3414855074</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital San Juan de Dios</name>
      <address>
        <city>Santa Cruz de la Sierra</city>
        <country>Bolivia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Victor Alanis, MD</last_name>
      <phone>591-70299888</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Japones</name>
      <address>
        <city>Santa Cruz de la Sierra</city>
        <country>Bolivia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital San Juan de Dios</name>
      <address>
        <city>Tarija</city>
        <country>Bolivia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto M Merida, MD</last_name>
      <phone>59170215050</phone>
    </contact>
    <contact_backup>
      <last_name>Siliva Lujan, MD</last_name>
      <phone>549-3415609329</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fundacion Clinica Campbell</name>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Romero, MD</last_name>
      <phone>573-1845392258</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609230</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinica Universitaria Rafael Uribe</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oscar Pinillos, MD</last_name>
      <phone>301-3765951</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Erasmo Meoz #1</name>
      <address>
        <city>Cucuta</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zulma Urbina, MD</last_name>
      <phone>573-134414353</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Erasmo Meoz #2</name>
      <address>
        <city>Cucuta</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jairo Figeroa, MD</last_name>
      <phone>573-3138534218</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Jose Carrasco Arteaga</name>
      <address>
        <city>Cuenca</city>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soraya Puertas, MD</last_name>
      <phone>593-99246924</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Espejo</name>
      <address>
        <city>Quito</city>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel E Jibaja, MD</last_name>
      <phone>593-99668588</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Luis Razetti</name>
      <address>
        <city>Barcelona</city>
        <country>Venezuela</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacobo Mora, MD</last_name>
      <phone>58-4142471196</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Luis Razetti</name>
      <address>
        <city>Barinas</city>
        <country>Venezuela</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Davila</last_name>
      <phone>58-41456703</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Patrocinio Penuela Ruiz</name>
      <address>
        <city>Cristobal</city>
        <country>Venezuela</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giannina B Martinez, MD</last_name>
      <phone>58-4147119190</phone>
    </contact>
    <contact_backup>
      <last_name>Silvia Lujan, MD</last_name>
      <phone>549-3415609239</phone>
      <email>silviablujan@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Bolivia</country>
    <country>Colombia</country>
    <country>Ecuador</country>
    <country>Venezuela</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 10, 2014</lastchanged_date>
  <firstreceived_date>February 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Randall M. Chesnut</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Severe traumatic brain injury, intracranial hypertension, Latin America, observational study, outcomes assessments</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
